China bans buying or selling blood

China's top legislative body has passed a law on the 11th session of the Standing Committee of the 10th NPC to control spread of infectious diseases, especially AIDS and SARS.

The revisions improve the regulations for AIDS prevention and provide stricter prevention and control measures on SARS and bird flu. China Radio International reported Saturday.

The six-day 11th session of the Standing Committee of the 10th National People's Congress ended in Beijing today (Saturday). The session also passed a resolution to improve the jury system and a law on electronic signatures to promote online business in China.

The jury system resolution details the necessary qualifications for jurors and the types of cases which will use a jury. In addition, legislators approved amendments to other laws covering highways, corporations and securities.

The amendments cancel or change those clauses inconsistent with the Law on Administrative Licensing which took effect on July 1. China's President Hu Jintao has signed a series of presidential orders to offically issue these laws, reports Xinhua.

According to Reuters, state television said the law banned the buying and selling of blood and ruled out discrimination against people infected with, or suspected of having, contagious diseases.

The country has also had to battle recent outbreaks of SARS, a disease it was slow to acknowledge, and bird flu.

SARS emerged in southern China in late 2002 to spread round the world to infect 8,000 people in nearly 30 countries, devastating airline and tourism industries. Nearly 800 people died.

The second revised law deals with electronic signatures on business contracts. The amendments concern nine laws and one regulation on highways, corporations, securities, negotiable instruments, auctions, wildlife protection, fishing, agriculture, degree and land administration.

Read earlier news stories by PRAVDA.Ru

&to=http://' target=_blank>AIDS Spirals out of Control

&to=http://' target=_blank>AIDS: 4 Million at Risk in India

Subscribe to Pravda.Ru Telegram channel, Facebook, Twitter, YouTube, RSS!

Author`s name Editorial Team